Denis Odinokov’s Post

🔬 We're excited to share the new article investigating the role of the #HRD #RAD51 assay as a predictive biomarker for #VUS pathogenicity in #BRCA1 in #breast and #ovarian cancer. Learn more about our research here 👉 https://lnkd.in/dg2Fs2nz #oncologyresearch #biomarkers #cancer"

Here's a snippet from our latest episode of the Cancer Conversations series. In this episode, Niall Rochford, co-founder of Pancreatic Cancer Ireland, talks with Associate Professor in Translational Oncology in Trinity Translational Medicine Institute, Stephen Maher, about Pancreatic Cancer. They discuss the severity, causes, treatment and impact of this cancer and the research that is being carried out. Watch the full episode through the link below. 🔗 https://lnkd.in/eNmixXSt 🔗 Stephen Maher Niall Rochford #BreakthroughCancerResearch #MakeMoreSurvivors #CancerConversations #PancreaticCancer

“A Closer Look at Cancer Biomarkers” is a comprehensive review on the status of biological markers for various types of cancer. It aims to update readers on current developments on the subject. The contents are divided into 6 sections covering a wide range of biomarkers and their diagnostic applications. This volume is an indispensable tool for researchers working in the field of cancer, as well as for clinical oncologists. https://lnkd.in/euG9VYKS #newbook #cancer #biomarkers #medicine

🚀 ASCO 2024 Daily Highlight: Our latest Daily Highlight focuses on critical advancements in GI cancer research. Discover key studies on metastatic colon cancer, rectal cancer and MSI-high rectal cancer, presented by Prof Hans Prenen. Discover these updates.👇 For all ASCO 2024 videos, find the link in the comments! #MediMix #ASCO2024 #GICancer #OncologyInnovation

  At #IN8bio, we're at the forefront of exploring gamma delta (γδ) T cells, a powerful subpopulation of T cells, for cancer therapy. These cells bridge the innate and adaptive immune system and offer a unique approach to combating cancer with minimal toxicity to healthy cells.   Our research has significantly advanced the potential of γδ T-cell therapies, demonstrating their use across both solid and liquid cancers. Unlike traditional T-cell therapies that rely on antigen presentation, γδ T cells are activated through multiple cell surface receptors that can sense stress signals from tumor cells.   As we progress towards next-generation cell therapy approaches, the potential of γδ T cells provides a new weapon in our arsenal for the fight against cancer. Please check out our latest feature on these powerful cells… #CancerTherapy #GammaDeltaTCells #CellTherapy #Oncology #CancerZero

In the field of cancer research, accurately measuring cell proliferation is crucial for assessing the efficacy of therapeutic agents. However, researchers often experience challenges with metabolic-based assays or indirect markers. 💡 Read how Promega is addressing this need through the early access release of our Lumit® hKi-67 Immunoassay for Cell Proliferation. https://bit.ly/3xHyMbm #oncology #cancer #lifescience

Our study on the impact of molecular classes in stage IIIC endometrial cancer - Gabriella Schivardi International Journal of Gynecological Cancer (IJGC) Giuseppe Caruso Luigi De Vitis Giuseppe Cucinella https://lnkd.in/eirBCB_s #Cancer #Oncology #OncoDaily #IJGC #EndometrialCancer

Studying tumor-specific T cells can be tough because of their low levels in patient samples. Luckily, ELISpot and FluoroSpot assays offer a solution! These incredibly sensitive methods can detect one cell in a million, making them perfect for studying rare cells. Check out our white paper, "ELISpot in cancer research," for insights on how these assays have been used to study immune responses in various cancer studies. Get your copy here: https://hubs.li/Q02BHxBQ0

nRichDX's Mayer Saidian, Ph.D. presented a poster titled, "Exploring Liquid Biopsy for the Detection of Bladder Cancer: Unraveling RNA Fusions" at the American Association for Cancer Research (AACR) Special Conference, "Bladder Cancer: Transforming the Field." in Charlotte, NC. The Conference concludes today and a pdf of the poster will be available shortly. Please email: info@nrichdx.com to request a copy. #liquidbiopsy #SamplePrepMatters #oncologyresearch #cancerresearch #bladdercancer

In May, we acknowledge National Cancer Research Month #NCRM24. Despite the availability of effective cancer treatments, cancer often spreads within the body and invades healthy tissue. Metastasis occurs in all forms of cancer, and in one of the most common forms, colon cancer, metastases cause around 90 percent of all deaths. #Fightcancer Follow us on LinkedIn for more updates. #cancer #oncology #wntresearch #cancerresearch #innovation #drugdevelopment #NCRM24